Our Expertise

Key Potential and Challenges of COVID-19 Intranasal Vaccines

Key Potential and Challenges of COVID-19 Intranasal Vaccines



In a recent World Health Organization (WHO) livestream event, Chief Scientist Dr. Soumya Swaminathan shared with journalists on the logistical and therapeutic benefits of second-generation COVID-19 vaccines. One such promising type is the intranasal vaccine.

How can we support your business growth?

Contact us to discover new opportunities.

Contact Us

Contact Us

Looking for a trusted partner?

Contact us to explore how DKSH can help you achieve your goals.